Loading stock data…
Loading stock data…
US$0.62
Get one email when CNTX crosses your level. Checked every 15 minutes during market hours.
▲ +0.00 (0.42%)up today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
30.4
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.22
Bullish momentumMACD above its signal line (-0.29).
50-day average
1.49
Price belowShort-term trend reference.
200-day average
1.76
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Context Therapeutics Inc. is a biopharmaceutical company focused on advancing treatments for hormone-driven female cancers. Primarily, the company develops investigational therapies targeting estrogen receptors, aiming to innovate in areas of significant unmet medical need. Context Therapeutics operates within the life sciences and biotechnology sectors, engaging in research and development to combat cancers like breast and ovarian cancer. The company's approach involves optimizing therapeutic o…
www.contexttherapeutics.com4 strong buy · 11 buy · 1 hold · 0 sell · 0 strong sell (16 analysts, 2026-07-01)
4 strong buy · 10 buy · 1 hold · 0 sell · 0 strong sell (15 analysts, 2026-06-01)
4 strong buy · 11 buy · 1 hold · 0 sell · 0 strong sell (16 analysts, 2026-05-01)
4 strong buy · 11 buy · 1 hold · 0 sell · 0 strong sell (16 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-06 | -0.12 | -0.09 | ✓ Beat |
| 2026-03-23 | -0.11 | -0.14 | ✗ Miss |
| 2026-02-16 | -10.85 | -0.59 | ✓ Beat |
| 2025-12-03 | 0.27 | 0.45 | ✓ Beat |
| 2025-10-30 | 4.41 | 4.73 | ✓ Beat |
| 2025-08-06 | -0.05 | -0.09 | ✗ Miss |
Companies in the same industry, via Finnhub